Risperidone formulation in rumenic acid
Term · Oncology and biomedicine · MLC-T-ONC-016555
An orally bioavailable capsule formulation containing the antipsychotic agent risperidone suspended in the lipid rumenic acid, with potential antineoplastic activity. Upon administration of VAL401, risperidone may, through an as of yet not elucidated mechanism of action, reduce cellular activity and tumor cell proliferation in multiple cancers.
| Identifier | MLC-T-ONC-016555 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | risperidone lipid formulation VAL401 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016555",
"term": "Risperidone formulation in rumenic acid",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable capsule formulation containing the antipsychotic agent risperidone suspended in the lipid rumenic acid, with potential antineoplastic activity. Upon administration of VAL401, risperidone may, through an as of yet not elucidated mechanism of action, reduce cellular activity and tumor cell proliferation in multiple cancers.",
"synonyms": [
"risperidone lipid formulation VAL401"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/risperidone-formulation-in-rumenic-acid/"
}
Record 14,508 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.